Publication | Open Access
Blood Pressure in Patients With Migraine Treated With Monoclonal Anti-CGRP (Receptor) Antibodies
62
Citations
17
References
2022
Year
This study provides Class III evidence that anti-CGRP (receptor) antibodies increase BP when used to treat patients with migraine.
| Year | Citations | |
|---|---|---|
Page 1
Page 1